Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention ...

BioStem Technologies, Inc., a developer of placental-derived products for wound care, recently announced that patient ...

Basis Medical announced the completion of the first-in-human clinical procedures using the company’s Seclusion catheter to t ...

The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...

Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG ...

Teleflex: Manta Vascular Closure Device Bioresorbable implant: Following the use of 10–20 F device or sheaths (12–25 F OD) 0.035: Indicated for closure of femoral artery access sites while reducing ...

The FDA regulates medical devices under the Medical Devices Amendment of 1976, which now extends to > 8,000 manufacturers producing an estimated 190,000 distinct medical devices. 1,2 Spending on ...

StentIt, a Netherlands-based developer of stents with regenerative properties, announced the successful implantation of its resorb ...

Gore & Associates: Gore Viabahn Endoprosthesis With Heparin Bioactive Surface Nitinol/ePTFE, gold: 6–10: 0.018/0.014 (5–8 mm), 0.035 (5–13 mm) ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Thrombolex, Inc., a developer of treatments for arterial and venous thromboembolic diseases, announced the publication of the resu ...

Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...